J L Raoul
Overview
Explore the profile of J L Raoul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pracht M, Edeline J, Lenoir L, Latournerie M, Mesbah H, Audrain O, et al.
Int J Hepatol
. 2013 Mar;
2013:827649.
PMID: 23476792
Portal vein tumor thrombosis (PVTT) is a common complication of hepatocellular carcinoma (HCC) and has a negative impact on prognosis. This characteristic feature led to the rationale of the present...
12.
Ferrand F, Malka D, Bourredjem A, Allonier C, Bouche O, Louafi S, et al.
Eur J Cancer
. 2012 Aug;
49(1):90-7.
PMID: 22926014
Objective: To assess the impact of primary tumour resection on overall survival (OS) of patients diagnosed with stage IV colorectal cancer (CRC). Design: Among the 294 patients with non-resectable colorectal...
13.
Conroy T, Yataghene Y, Etienne P, Michel P, Senellart H, Raoul J, et al.
Br J Cancer
. 2010 Oct;
103(9):1349-55.
PMID: 20940718
Background: Concurrent chemoradiotherapy is a valuable treatment option for localised oesophageal cancer (EC), but improvement is still needed. A randomised phase II trial was initiated to assess the feasibility and...
14.
Collette S, Bonnetain F, Paoletti X, Doffoel M, Bouche O, Raoul J, et al.
Ann Oncol
. 2008 Feb;
19(6):1117-26.
PMID: 18303031
Objective: The objective of this study was to assess the performance of three staging systems [Okuda, Cancer of the Liver Italian Program (CLIP) and Barcelona Clinic Liver Cancer group (BCLC)],...
15.
Michel P, Adenis A, Di Fiore F, Boucher E, Galais M, Dahan L, et al.
Br J Cancer
. 2006 Sep;
95(6):705-9.
PMID: 16967056
A recent phase I study showed that weekly cisplatin, irinotecan and concurrent radiotherapy can be administered with moderate toxicity in patients with oesophageal cancer. Patients with no prior treatment and...
16.
Ducreux M, Bouche O, Pignon J, Mousseau M, Raoul J, Cassan P, et al.
Oncology
. 2006 Jul;
70(3):222-30.
PMID: 16816536
LV5FU2 with high-dose leucovorin (LV), weekly infusional 5-fluorouracil (5FU) (AIO schedule) and raltitrexed have been demonstrated to be active agents in first-line treatment of colorectal cancer. We performed a 4-arm...
17.
Briasoulis E, Pavlidis N, Terret C, Bauer J, Fiedler W, Schoffski P, et al.
Eur J Cancer
. 2003 Oct;
39(16):2334-40.
PMID: 14556925
The activity of glufosfamide (beta-D-glucopyranosyl-N,N'-di-(2-chloroethyl)-phosphoric acid diamide) against pancreatic cancer was investigated in a multicentre, phase II clinical study. Chemotherapy-nai;ve patients with advanced or metastatic disease were treated with glufosfamide...
18.
Ychou M, Raoul J, Desseigne F, Borel C, Caroli-Bosc F, Jacob J, et al.
Cancer Chemother Pharmacol
. 2002 Nov;
50(5):383-91.
PMID: 12439596
Purpose: The efficacy and safety of single-agent, high-dose irinotecan (CPT-11, Campto) 500 mg/m(2) every 3 weeks were investigated as first-line treatment for advanced colorectal cancer (CRC). Patients And Methods: Patients...
19.
Egreteau J, Boucher E, Lesimple T, Le Prise E, Raoul J
Bull Cancer
. 2001 Dec;
88(11):1091-3.
PMID: 11741803
The authors report two cases of severe bilateral interstitial pneumopathies occurring after a medical treatment for esophageal carcinoma. In both cases a broncho-alveolar lavage revealed the presence of herpes virus...
20.
Becouarn Y, Gamelin E, Coudert B, Negrier S, Pierga J, Raoul J, et al.
J Clin Oncol
. 2001 Nov;
19(22):4195-201.
PMID: 11709562
Purpose: To assess antitumor activity and safety of two regimens in advanced colorectal cancer (CRC) patients with proven fluorouracil (5-FU) resistance in a randomized phase II study: 5-FU/folinic acid (FA)...